Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 1
2011 1
2012 1
2013 1
2016 2
2017 3
2018 6
2019 5
2020 8
2021 11
2022 10
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Irreversible inhibition of estrogen receptor α signaling and the emergence of hormonal resistance in MCF7 breast cancer cells induced by DNA damage agents.
Scherbakov AM, Sorokin DV, Razuvaeva VE, Shchegolev YY, Andreeva OE, Salnikova DI, Fetisov TI, Vlasova OA, Kirsanov KI, Gudkova MV, Krasil'nikov MA. Scherbakov AM, et al. Biomed Rep. 2024 Jan 19;20(3):42. doi: 10.3892/br.2024.1727. eCollection 2024 Mar. Biomed Rep. 2024. PMID: 38343657 Free PMC article.
Secosteroid thiosemicarbazides and secosteroid-1,2,4-triazoles as antiproliferative agents targeting breast cancer cells: Synthesis and biological evaluation.
Ilovaisky AI, Scherbakov AM, Chernoburova EI, Povarov AA, Shchetinina MA, Merkulova VM, Salnikova DI, Sorokin DV, Bozhenko EI, Zavarzin IV, Terent'ev AO. Ilovaisky AI, et al. Among authors: scherbakov am. J Steroid Biochem Mol Biol. 2023 Nov;234:106386. doi: 10.1016/j.jsbmb.2023.106386. Epub 2023 Sep 2. J Steroid Biochem Mol Biol. 2023. PMID: 37666392
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells.
Scherbakov AM, Vorontsova SK, Khamidullina AI, Mrdjanovic J, Andreeva OE, Bogdanov FB, Salnikova DI, Jurisic V, Zavarzin IV, Shirinian VZ. Scherbakov AM, et al. Invest New Drugs. 2023 Feb;41(1):142-152. doi: 10.1007/s10637-023-01332-z. Epub 2023 Jan 25. Invest New Drugs. 2023. PMID: 36695998 Free PMC article.
Secosteroid-quinoline hybrids as new anticancer agents.
Ilovaisky AI, Scherbakov AM, Merkulova VM, Chernoburova EI, Shchetinina MA, Andreeva OE, Salnikova DI, Zavarzin IV, Terent'ev AO. Ilovaisky AI, et al. Among authors: scherbakov am. J Steroid Biochem Mol Biol. 2023 Apr;228:106245. doi: 10.1016/j.jsbmb.2022.106245. Epub 2023 Jan 3. J Steroid Biochem Mol Biol. 2023. PMID: 36608906
Indoline-5-Sulfonamides: A Role of the Core in Inhibition of Cancer-Related Carbonic Anhydrases, Antiproliferative Activity and Circumventing of Multidrug Resistance.
Krymov SK, Scherbakov AM, Dezhenkova LG, Salnikova DI, Solov'eva SE, Sorokin DV, Vullo D, De Luca V, Capasso C, Supuran CT, Shchekotikhin AE. Krymov SK, et al. Among authors: scherbakov am. Pharmaceuticals (Basel). 2022 Nov 23;15(12):1453. doi: 10.3390/ph15121453. Pharmaceuticals (Basel). 2022. PMID: 36558903 Free PMC article.
52 results